A total of 30 modifiable risk factors account for almost 40% of new cancer cases globally, a landmark study from the World ...

Health Union continues to address the profound isolation ofte felt within the rare disease community. With the launch of PrimaryBiliaryCholangitis.net and Idiopathic-Hypersomnia.net, the company is ...

Strangely, I felt calm and prepared. I knew catching it early was key, and I knew about the range of treatment options ...

The City of Springfield is observing its first Cholangiocarcinoma Awareness Month this February, lighting local landmarks ...

February is Cholangiocarcinoma Awareness Month, a time to shine a light on this disease and the people it affects ...

Sydney Towle, 26, has documented her journey with a rare, aggressive bile duct cancer since she was diagnosed in 2023 ...

By: Tommie HartCholangiocarcinoma, or bile duct cancer, is one of the most challenging and under-recognized cancers, with ...

Elevar Therapeutics Inc. appointed Kim Dong-gun (DG) as CEO Jan. 29, as the company focuses on post-NDA strategies for lirafugratinib in bile duct cancer, and the twice-rejected ...

A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

When do you have tests for bile duct cancer? Bile duct cancer is also called cholangiocarcinoma. It is a rare type of cancer that develops in the bile ducts. Most people are diagnosed with bile duct ...